Broadband pulsed light therapy and silicon magnetophoresis for rosacea in a patient taking glp-1 receptor agonists for weight loss
Regenerative biotechnologies, preventive, digital and predictive medicine · 19.03.2026 · 3 (1) · 44
DOI: 10.17116/rbpdpm2026301144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative biotechnologies, preventive, digital and predictive medicine, erschienen am 19.03.2026. Verfasst von E.V. Filatova und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
The authors present examination and treatment of a patient with erythematotelangiectatic subtype of rosacea. Treatment included broadband-pulsed light therapy and silicon magnetophoresis applied to skin areas with vascular lesions. Silicon magnetophoresis in addition to light therapy resulted in faster regression of facial skin lesions in a patient taking weight-loss medications and GLP-1 receptor antagonists.
Zitieren
APA
Filatova, E., & Konopatkina, I. (2026). Broadband pulsed light therapy and silicon magnetophoresis for rosacea in a patient taking glp-1 receptor agonists for weight loss. Regenerative biotechnologies, preventive, digital and predictive medicine, 3(1), 44. https://doi.org/10.17116/rbpdpm2026301144
Vancouver
Filatova E, Konopatkina I. Broadband pulsed light therapy and silicon magnetophoresis for rosacea in a patient taking glp-1 receptor agonists for weight loss. Regenerative biotechnologies, preventive, digital and predictive medicine. 2026;3(1):44. doi:10.17116/rbpdpm2026301144
BibTeX
@article{Filatova2026,
author = {Filatova, E.V. and Konopatkina, I.Yu.},
title = {Broadband pulsed light therapy and silicon magnetophoresis for rosacea in a patient taking glp-1 receptor agonists for weight loss},
journal = {Regenerative biotechnologies, preventive, digital and predictive medicine},
year = {2026},
volume = {3},
number = {1},
pages = {44},
doi = {10.17116/rbpdpm2026301144}
}
EUVIMED